Related content

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?

By Novo Salvatore   Fazio Giovanni   Raccuglia Elena  

Pharmaceuticals, Vol. 2, Iss. 3, 2009-11 ,pp. : 118-124

MDPI

Access to resources Recommend Favorite

Correction: Hong, K. et al. Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China. Mar. Drugs 2009, 7, 24–44

By Hong Kui   Gao An-Hui   Xie Qing-Yi   Gao Hao   Zhuang Ling   Lin Hai-Peng   Yu Hai-Ping   Li Jia   Yao Xin-Sheng   Goodfellow Michael   Ruan Ji-Sheng  

Marine Drugs, Vol. 7, Iss. 4, 2009-10 ,pp. : 495-496

MDPI

Access to resources Recommend Favorite

Resumed Publication of Pharmaceuticals in 2009

By Lin Shu-Kun   McPhee Derek J.  

Pharmaceuticals, Vol. 2, Iss. 1, 2009-04 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface

By Bestgen Benoît   Belaid-Choucair Zakia   Lomberget Thierry   Le Borgne Marc   Filhol Odile   Cochet Claude  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 16-16

MDPI

Access to resources Recommend Favorite

Correction: Kikuchi, K., et al., Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci. 2013, 14, 18899–18924.

By Kikuchi Kiyoshi   Tancharoen Salunya   Ito Takashi   Morimoto-Yamashita Yoko   Miura Naoki   Kawahara Ko-ichi   Maruyama Ikuro   Murai Yoshinaka   Tanaka Eiichiro  

International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-03 ,pp. : 5410-5411

MDPI

Access to resources Recommend Favorite